Get Your Personalized Supplement StackSupplement Stack Quiz

Uva Ursi Leaves Powder

Also known as: Uva ursi, bearberry, Arctostaphylos uva-ursi

Overview

Uva ursi leaves powder is derived from the dried leaves of the evergreen shrub Arctostaphylos uva-ursi. It is traditionally used as a herbal supplement and urinary antiseptic agent, primarily for the management of urinary tract infections (UTIs). The plant contains active compounds, notably arbutin, which is metabolized in the body to hydroquinone. Hydroquinone is the key component responsible for the antibacterial properties of uva ursi, particularly against common urinary pathogens like Escherichia coli. Research on uva ursi's efficacy is moderately mature, with some clinical trials and systematic reviews available, though the overall quality and consistency of high-quality randomized controlled trial (RCT) data remain somewhat limited. Despite mixed evidence quality, it is recognized for its potential role in providing symptom relief in acute uncomplicated cystitis.

Benefits

Uva ursi's primary benefit lies in its antibacterial activity against urinary pathogens, especially *Escherichia coli*, the most frequent cause of uncomplicated UTIs. This effect is attributed to arbutin, which, when hydrolyzed to hydroquinone in alkaline urine, inhibits bacterial growth. Clinical trials suggest its potential for symptom relief in acute uncomplicated cystitis. A 2025 systematic review and meta-analysis indicated that uva ursi extracts exhibit in vitro antibacterial activity and some clinical efficacy, though the magnitude of effect varies. The 2017 ATAFUTI study showed promising results for reducing symptoms and antibiotic use in women with UTIs, while a 2022 study suggested bearberry extract might be non-inferior to antibiotics for symptom improvement and bacteriuria reduction in uncomplicated cystitis, without reported resistance. While promising, larger and more definitive studies are needed to solidify these findings.

How it works

The primary mechanism of action for uva ursi involves its main active compound, arbutin. Upon ingestion, arbutin is absorbed and then metabolized. Crucially, in alkaline urine, arbutin undergoes hydrolysis to form hydroquinone. Hydroquinone acts as a potent urinary antiseptic by directly inhibiting the growth of urinary pathogens, such as *Escherichia coli* and *Staphylococcus aureus*, by disrupting their cellular functions. The effectiveness of this conversion and subsequent antibacterial action is highly dependent on the pH of the urine; an alkaline environment is necessary for optimal hydrolysis of arbutin to its active form, hydroquinone. In vitro studies have confirmed that uva ursi extracts can inhibit bacterial growth at concentrations achievable in the urinary tract.

Side effects

Uva ursi is generally considered safe for short-term use, typically up to two weeks. The most commonly reported side effects are mild gastrointestinal discomfort, which may include nausea or stomach upset. However, due to the potential for toxicity from hydroquinone, uva ursi is strictly contraindicated in several populations. These include pregnant women, lactating mothers, and children, as there is insufficient safety data for these groups and potential risks to development. Patients with pre-existing renal disease should also avoid uva ursi due to the risk of exacerbating kidney conditions. While no significant drug interactions have been widely reported in high-quality studies, caution is advised, especially with prolonged use, given the potential for hydroquinone toxicity. Long-term or excessive use can lead to liver damage, kidney damage, and other systemic toxicities, making adherence to recommended short-term usage crucial.

Dosage

For uva ursi, the recommended dosage varies depending on the form of preparation. When consumed as a tea, one teaspoon of dried uva ursi leaves should be steeped in boiling water, and this preparation can be taken 3-4 times daily. For standardized capsule extracts, a common dosage is 700–1000 mg, taken three times daily. If using a tincture, the typical recommendation is one teaspoon, three times daily. It is critical to note that uva ursi should not be used for more than 14 consecutive days to mitigate the risk of toxicity. Optimal dosing and efficacy are also influenced by the standardization of the extract for arbutin content and the maintenance of an alkaline urinary pH, which is essential for the conversion of arbutin to its active form, hydroquinone.

FAQs

Is uva ursi effective for UTIs?

Evidence supports uva ursi's antibacterial activity and potential for symptom relief in uncomplicated UTIs, but it should not replace antibiotics for severe infections.

Is it safe long-term?

No, uva ursi is not safe for long-term use. Its use should be strictly limited to short courses, typically no more than two weeks, to avoid potential toxicity.

Can it reduce antibiotic use?

Some trials suggest uva ursi may help reduce antibiotic consumption by alleviating UTI symptoms, but more large-scale randomized controlled trials are needed to confirm this.

Who should avoid it?

Pregnant or lactating women, children, and individuals with kidney disease should avoid using uva ursi due to potential safety concerns and lack of sufficient data.

Research Sources

https://journalejmp.com/index.php/EJMP/article/download/1264/2596/2346 – This systematic review and meta-analysis from 2025 found that uva ursi extracts demonstrate in vitro antibacterial activity and some clinical efficacy in relieving UTI symptoms. However, the study noted significant variability in research designs and extract preparations, limiting definitive conclusions despite indicating moderate potency.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5591533/ – The ATAFUTI Trial, a double-blind, placebo-controlled RCT from 2017, investigated uva ursi's potential to reduce symptoms and antibiotic use in women with acute UTIs. While the trial was ongoing or planned at the time of publication, its design was considered high-quality, suggesting promising results for symptom management when combined with ibuprofen.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9234905/ – This 2022 randomized controlled trial assessed bearberry extract's non-inferiority to antibiotics in treating uncomplicated cystitis. The study found that bearberry extract was comparable to antibiotics in improving symptoms and reducing bacteriuria, with no reported resistance, though the small sample size limits generalizability.
https://www.va.gov/WHOLEHEALTHLIBRARY/tools/urinary-tract-infections.asp – This source provides general information on urinary tract infections and mentions uva ursi as a traditional remedy. It highlights the importance of short-term use and lists contraindications, including pregnancy, lactation, children, and kidney disease, due to potential toxicity and lack of safety data.